Bioiberica S.A.U.

Bioiberica S.A.U.


Company description

Bioiberica is a global biopharmaceutical company, committed to improving the health and well-being of people, animals and plants. Our core business is the identification and extraction of biomolecules of high biological and therapeutic value from animal origin for the pharmaceutical and nutraceutical industries. This specialization has made us become the leading Heparin API producer and a world reference in the production and sale of joint health and mobility compounds such us Chondroitin Sulfate, Glucosamine, Hyaluronic Acid and Native Type II Collagen. We also offer other animal-derived active ingredients such as Thyroid and Trypsin and other biological APIS currently under development in our pipeline. Bioiberica is vertically integrated, being present throughout the whole life of the product, from development through production to marketing, and our processes are especially designed to minimize any possibility of biological risk. Our products are supported by more than 150 scientific publications.

Quick facts

Sales markets Western Europe, Eastern Europe, Middle East, Asia, Australia, North America, Africa, Central/South America
Affiliated categories: Animal Extracts |APIs |Finished Dosage Formulations More

Recently at

9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 14.0F40 See our Exhibitor Profile   See full Exhibitor List
20 jun 2018

CPhI & PMEC China 2018

20 - 22 June, 2018 Shanghai, China We were at stand E1Q18, E1Q18 See our Exhibitor Profile   See full Exhibitor List
Bioiberica S.A.U.

Contact information




View all contact information